Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 29.00
+0.60 (2.11%)
Sep 30, 2026, 1:30 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 3.54 billion as of September 29, 2026. Its market cap has decreased by -38.53% in one year.
Market Cap
3.54B
Enterprise Value
3.46B
Revenue
799.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.00
ChartMarket Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 3.54B, an increase of 691.51%. That is a compound annual growth rate of 11.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 3.54B | -20.67% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.83B |
| Formosa Laboratories | 5.74B |
| LIWANLI Innovation | 4.74B |
| Panion & Bf Biotech | 4.60B |
| Orient EuroPharma | 4.00B |
| Maywufa Company | 2.77B |
| Allied Biotech | 2.75B |
| Merdury Biopharmaceutical | 2.45B |